UnitedHealth Group Incorporated (UNH) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$363.87
Price Target
$385.43
Target Range
$327.00 — $444.00
Analyst Rating
Buy
Forward P/E19.9x
Trailing P/E27.5x
Forward PEG—
Implied Growth+38.3%
Median Target$380.00
Analyst Spread30.4%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$327
-10.1%
Consensus
$385
+5.9%
Bull Case
$444
+22.0%
Valuation Model TargetsConfidence: 86/100
Bear$380
Base$559
Bull$1052
UNH Price Target Analysis
Updated May 6, 2026As of May 6, 2026, UnitedHealth Group Incorporated (UNH) has a Wall Street consensus price target of $385.43, based on estimates from 52 covering analysts. With the stock currently trading at $363.87, this represents a potential upside of +5.9%. The company has a market capitalization of $330.28B.
Analyst price targets range from a low of $327.00 to a high of $444.00, representing a 30% spread in expectations. The median target of $380.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 42 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 4 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, UNH trades at a trailing P/E of 27.5x and forward P/E of 19.9x. Analysts expect EPS to grow +38.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $558.98, with bear and bull scenarios of $379.60 and $1052.16 respectively. Model confidence stands at 86/100, indicating high predictability in the company's fundamentals.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+9.5%
Avg Forward P/E36.6x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CVSCVS Health Corporation | $102.6B | $80.69 | $95.20 | +18.0% | Buy | 11.3x | 41 |
 ELVElevance Health Inc. | $80.1B | $369.07 | $382.38 | +3.6% | Buy | 13.8x | 37 |
 CICigna Corporation | $72.7B | $275.66 | $328.00 | +19.0% | Buy | 9.1x | 39 |
 HUMHumana Inc. | $28.8B | $239.53 | $246.00 | +2.7% | Hold | 26.8x | 44 |
 CNCCentene Corporation | $26.2B | $52.97 | $51.00 | -3.7% | Buy | 15.7x | 43 |
 MOHMolina Healthcare, Inc. | $10.0B | $192.17 | $166.09 | -13.6% | Buy | 37.3x | 38 |
 HCSGHealthcare Services Group, Inc. | $1.6B | $21.73 | $24.50 | +12.7% | Hold | 20.3x | 15 |
 OSCROscar Health, Inc. | $4.7B | $17.94 | $16.75 | -6.6% | Hold | 29.8x | 11 |
 CLOVClover Health Investments, Corp. | $1.3B | $2.61 | $3.33 | +27.6% | Hold | 61.0x | 9 |
 ALHCAlignment Healthcare, Inc. | $3.7B | $18.30 | $24.83 | +35.7% | Buy | 141.3x | 16 |
Upside Potential Comparison
ALHCCLOVCICVSHCSGELVHUMCNCFull UNH Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy UNH Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See UNH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs UNH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare UNH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonUNH — Frequently Asked Questions
Quick answers to the most common questions about buying UNH stock.
What is the UNH stock price target for 2026?
The consensus price target for UNH is $385.43, close to the current price of $363.87 (5.9% implied move). Based on 52 analyst estimates, the stock appears fairly valued near current levels.
Is UNH a buy, sell, or hold?
UNH has a consensus rating of "Buy" based on 52 Wall Street analysts. The rating breakdown is predominantly bullish, with 42 Buy/Strong Buy ratings. The consensus 12-month price target of $385.43 implies 5.9% upside from current levels.
Is UNH stock overvalued or undervalued?
With a forward P/E of 19.8743x, UNH trades at a relatively low valuation. The consensus target of $385.43 implies 5.9% appreciation, suggesting the market may be pricing in risks.
How high can UNH stock go?
The most bullish Wall Street analyst has a price target of $444 for UNH, while the most conservative target is $327. The consensus of $385.43 represents the median expectation. Our quantitative valuation model projects a bull case target of $1052 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover UNH stock?
UNH is heavily covered by Wall Street, with 52 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 42 have Buy ratings, 6 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the UNH stock forecast?
The 12-month UNH stock forecast based on 52 Wall Street analysts shows a consensus price target of $385.43, with estimates ranging from $327 (bear case) to $444 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $559, with bear/bull scenarios of $380/$1052.
What is UNH's fair value based on fundamentals?
Our quantitative valuation model calculates UNH's fair value at $559 (base case), with a bear case of $380 and bull case of $1052. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 86/100.
What is UNH's forward P/E ratio?
UNH trades at a forward P/E ratio of 19.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 27.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy UNH stock?
UNH appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $385.43 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do UNH price targets vary so much?
UNH analyst price targets range from $327 to $444, a 30% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $385.43 consensus represents the middle ground. Our model's $380-$1052 range provides an independent fundamental perspective.